Login

Mr. Nitin Verma, CEO of Mirae Asset Global Indices, unveils the future of ETFs at Innowave. 00:10:00

Share On Facebook Share On Twitter

Kim, Mi Seob · President & CEO, Mirae Asset Global Investments

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
JLL's CEO Christian Ulbrich on Commercial Real Estate Revival and Data Center Boom
00:00:00
Jason Conroy, CEO, MMJ Phytotech Ltd
00:10:00
EXORE Resources' Strategic Exploration and Expansion in Cote d'Ivoire: Insights from the One-to-One Mining Investment Conference
00:10:00
Childhood Memories and Sibling Bonds|Madison Farkas,Professor,University of Wisconsin
00:10:00
Abiding commitment to public service that dates back for decades|Harrison J Buzz Frahn,Partner,Simpson Thacher
00:10:00
Biopharmaceutical company focused on the development and commercialization of firstinclass critical care products|Myron Holubiak,CEO,Citius Pharmaceuticals
00:10:00
Trailblazing Conversations: Abby Johnson and Mike Bloomberg on Leadership, Innovation, and City Building| Abigail Johnson, CEO , Fidelity Investments LLC .
00:10:00
Exploring Axalta's Industrial Coatings Division | Chris Villavarayan - CEO of Axalta Coating Systems
00:10:00
Exploring Nunavut's Rich Mineral Resources: Driving Economic Growth | Tom Hoefer - Executive Director of NWT & Nunavut Chamber Of Mines
00:10:00
Cornwall Advances Floating Offshore Wind Projects in the Celtic Sea
00:10:00
Jason PTZ on OTC Markets Group’s Global Expansion and Its Benefits for International Companies
00:10:00
Private Equity's Role in Sustainable Resource Investing

© 2017 - Neuhu+